US Stock MarketDetailed Quotes

Aethlon Medical (AEMD)

Watchlist
  • 2.140
  • -0.050-2.28%
Close May 13 16:00 ET
  • 2.140
  • 0.0000.00%
Post 17:43 ET
3.36MMarket Cap-0.04P/E (TTM)

Aethlon Medical (AEMD) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
6.78%-1.87M
25.10%-1.66M
1.87%-1.71M
24.52%-7.65M
34.80%-1.67M
15.44%-2.01M
18.11%-2.21M
29.60%-1.75M
3.57%-10.13M
12.94%-2.57M
Net income from continuing operations
-15.01%-2.02M
47.02%-1.49M
31.48%-1.76M
-9.66%-13.39M
-157.89%-6.25M
49.37%-1.75M
7.50%-2.81M
21.65%-2.57M
-1.48%-12.21M
1.68%-2.43M
Operating gains losses
----
----
----
----
----
----
----
----
-85.13%21.14K
--17.86K
Depreciation and amortization
-2.63%81.6K
-6.95%79.87K
-3.98%82.64K
-5.43%339.56K
-2.29%83.86K
-8.38%83.81K
-6.13%85.83K
-4.72%86.06K
49.05%359.06K
7.91%85.83K
Other non cash items
4.57%73.91K
-47.90%73.08K
6,038.37%72.27K
3,422,326.57%4.89M
385,641.56%4.68M
12,587.63%70.68K
20,348.54%140.28K
-198.30%-1.22K
-99.41%143
-218.77%-1.22K
Change In working capital
83.20%-84.07K
-257.03%-397.01K
-130.08%-180.43K
-80.43%93.69K
32.29%-258.39K
-218.83%-500.46K
1,431.75%252.82K
30.91%599.73K
632.58%478.66K
53.50%-381.63K
-Change in receivables
----
----
----
----
----
----
----
----
--0
----
-Change in prepaid assets
172.09%344.59K
-140.84%-82.57K
82.52%164.03K
1,213.40%113.92K
-4.23%-304.8K
210.55%126.65K
112.84%202.2K
-38.62%89.87K
-102.57%-10.23K
-355.34%-292.42K
-Change in payables and accrued expense
31.64%-428.66K
-721.16%-314.43K
-167.56%-344.46K
-104.14%-20.23K
152.02%46.4K
-264.87%-627.11K
144.41%50.62K
63.57%509.86K
520.56%488.89K
75.29%-89.2K
Cash from discontinued investing activities
Operating cash flow
6.78%-1.87M
25.10%-1.66M
1.87%-1.71M
24.52%-7.65M
34.80%-1.67M
15.44%-2.01M
18.11%-2.21M
29.60%-1.75M
3.57%-10.13M
12.94%-2.57M
Investing cash flow
Cash flow from continuing investing activities
0
144.67%2.19K
75.11%-2.19K
0
0
73.40%-250.87K
56.53%-4.91K
Net PPE purchase and sale
----
----
----
--0
144.67%2.19K
75.11%-2.19K
--0
--0
73.40%-250.87K
56.53%-4.91K
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
144.67%2.19K
75.11%-2.19K
--0
--0
73.40%-250.87K
56.53%-4.91K
Financing cash flow
Cash flow from continuing financing activities
42,269.31%2.98M
97,728.44%3.74M
-100.10%-5.36K
500.14%7.73M
5,441.34%2.36M
-103.99%-7.07K
61.07%-3.83K
399.12%5.38M
-85.56%1.29M
1,715.02%42.57K
Net common stock issuance
--4.01M
--3.74M
--0
167.69%3.54M
-3,806.44%-1.84M
--0
--0
395.74%5.38M
-85.19%1.32M
--49.76K
Proceeds from stock option exercised by employees
----
----
----
--4.37M
----
----
----
----
--0
----
Net other financing activities
-14,361.20%-1.02M
12.73%-3.34K
-5.49%-5.36K
-428.45%-183.78K
-2,233.80%-167.8K
24.54%-7.07K
61.07%-3.83K
39.35%-5.08K
-178.38%-34.78K
-172.76%-7.19K
Cash from discontinued financing activities
Financing cash flow
42,269.31%2.98M
97,728.44%3.74M
-100.10%-5.36K
500.14%7.73M
5,441.34%2.36M
-103.99%-7.07K
61.07%-3.83K
399.12%5.38M
-85.56%1.29M
1,715.02%42.57K
Net cash flow
Beginning cash position
-14.32%5.95M
-57.82%3.86M
1.26%5.6M
-62.18%5.53M
-39.04%4.91M
-32.32%6.95M
-29.46%9.16M
-62.18%5.53M
-14.80%14.62M
-54.17%8.06M
Current changes in cash
154.78%1.11M
193.87%2.08M
-147.37%-1.72M
100.90%81.85K
127.24%688.6K
8.57%-2.02M
18.46%-2.22M
322.12%3.63M
-258.91%-9.09M
14.62%-2.53M
Effect of exchange rate changes
74.62%-3.46K
22.95%6.25K
-1,101.24%-15.5K
-681.96%-12.26K
-7.31%-2.42K
-343.26%-13.64K
581.99%5.09K
-593.55%-1.29K
135.37%2.11K
62.11%-2.26K
End cash Position
43.60%7.06M
-14.32%5.95M
-57.82%3.86M
1.26%5.6M
1.26%5.6M
-39.04%4.91M
-32.32%6.95M
-29.46%9.16M
-62.18%5.53M
-62.18%5.53M
Free cash flow
6.80%-1.88M
25.10%-1.66M
1.87%-1.71M
26.35%-7.65M
35.01%-1.67M
15.66%-2.01M
18.31%-2.21M
35.58%-1.75M
9.33%-10.38M
13.11%-2.57M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 6.78%-1.87M25.10%-1.66M1.87%-1.71M24.52%-7.65M34.80%-1.67M15.44%-2.01M18.11%-2.21M29.60%-1.75M3.57%-10.13M12.94%-2.57M
Net income from continuing operations -15.01%-2.02M47.02%-1.49M31.48%-1.76M-9.66%-13.39M-157.89%-6.25M49.37%-1.75M7.50%-2.81M21.65%-2.57M-1.48%-12.21M1.68%-2.43M
Operating gains losses ---------------------------------85.13%21.14K--17.86K
Depreciation and amortization -2.63%81.6K-6.95%79.87K-3.98%82.64K-5.43%339.56K-2.29%83.86K-8.38%83.81K-6.13%85.83K-4.72%86.06K49.05%359.06K7.91%85.83K
Other non cash items 4.57%73.91K-47.90%73.08K6,038.37%72.27K3,422,326.57%4.89M385,641.56%4.68M12,587.63%70.68K20,348.54%140.28K-198.30%-1.22K-99.41%143-218.77%-1.22K
Change In working capital 83.20%-84.07K-257.03%-397.01K-130.08%-180.43K-80.43%93.69K32.29%-258.39K-218.83%-500.46K1,431.75%252.82K30.91%599.73K632.58%478.66K53.50%-381.63K
-Change in receivables ----------------------------------0----
-Change in prepaid assets 172.09%344.59K-140.84%-82.57K82.52%164.03K1,213.40%113.92K-4.23%-304.8K210.55%126.65K112.84%202.2K-38.62%89.87K-102.57%-10.23K-355.34%-292.42K
-Change in payables and accrued expense 31.64%-428.66K-721.16%-314.43K-167.56%-344.46K-104.14%-20.23K152.02%46.4K-264.87%-627.11K144.41%50.62K63.57%509.86K520.56%488.89K75.29%-89.2K
Cash from discontinued investing activities
Operating cash flow 6.78%-1.87M25.10%-1.66M1.87%-1.71M24.52%-7.65M34.80%-1.67M15.44%-2.01M18.11%-2.21M29.60%-1.75M3.57%-10.13M12.94%-2.57M
Investing cash flow
Cash flow from continuing investing activities 0144.67%2.19K75.11%-2.19K0073.40%-250.87K56.53%-4.91K
Net PPE purchase and sale --------------0144.67%2.19K75.11%-2.19K--0--073.40%-250.87K56.53%-4.91K
Cash from discontinued investing activities
Investing cash flow --------------0144.67%2.19K75.11%-2.19K--0--073.40%-250.87K56.53%-4.91K
Financing cash flow
Cash flow from continuing financing activities 42,269.31%2.98M97,728.44%3.74M-100.10%-5.36K500.14%7.73M5,441.34%2.36M-103.99%-7.07K61.07%-3.83K399.12%5.38M-85.56%1.29M1,715.02%42.57K
Net common stock issuance --4.01M--3.74M--0167.69%3.54M-3,806.44%-1.84M--0--0395.74%5.38M-85.19%1.32M--49.76K
Proceeds from stock option exercised by employees --------------4.37M------------------0----
Net other financing activities -14,361.20%-1.02M12.73%-3.34K-5.49%-5.36K-428.45%-183.78K-2,233.80%-167.8K24.54%-7.07K61.07%-3.83K39.35%-5.08K-178.38%-34.78K-172.76%-7.19K
Cash from discontinued financing activities
Financing cash flow 42,269.31%2.98M97,728.44%3.74M-100.10%-5.36K500.14%7.73M5,441.34%2.36M-103.99%-7.07K61.07%-3.83K399.12%5.38M-85.56%1.29M1,715.02%42.57K
Net cash flow
Beginning cash position -14.32%5.95M-57.82%3.86M1.26%5.6M-62.18%5.53M-39.04%4.91M-32.32%6.95M-29.46%9.16M-62.18%5.53M-14.80%14.62M-54.17%8.06M
Current changes in cash 154.78%1.11M193.87%2.08M-147.37%-1.72M100.90%81.85K127.24%688.6K8.57%-2.02M18.46%-2.22M322.12%3.63M-258.91%-9.09M14.62%-2.53M
Effect of exchange rate changes 74.62%-3.46K22.95%6.25K-1,101.24%-15.5K-681.96%-12.26K-7.31%-2.42K-343.26%-13.64K581.99%5.09K-593.55%-1.29K135.37%2.11K62.11%-2.26K
End cash Position 43.60%7.06M-14.32%5.95M-57.82%3.86M1.26%5.6M1.26%5.6M-39.04%4.91M-32.32%6.95M-29.46%9.16M-62.18%5.53M-62.18%5.53M
Free cash flow 6.80%-1.88M25.10%-1.66M1.87%-1.71M26.35%-7.65M35.01%-1.67M15.66%-2.01M18.31%-2.21M35.58%-1.75M9.33%-10.38M13.11%-2.57M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More